Viewing Study NCT01187966


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2025-12-31 @ 7:00 PM
Study NCT ID: NCT01187966
Status: COMPLETED
Last Update Posted: 2010-08-24
First Post: 2010-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease
Sponsor: Newron Pharmaceuticals SPA
Organization: